UiPath (NYSE:PATH – Get Free Report) posted its quarterly earnings data on Wednesday. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.14 by ($0.11), Zacks reports. UiPath had a return on equity of 1.28% and a net margin of 1.35%.
UiPath Trading Up 4.2%
Shares of UiPath stock traded up $0.60 on Wednesday, hitting $14.90. 38,556,340 shares of the company traded hands, compared to its average volume of 14,864,771. The company has a market cap of $7.91 billion, a PE ratio of 496.53, a PEG ratio of 5.22 and a beta of 1.10. The stock’s 50 day moving average price is $14.62 and its 200-day moving average price is $12.97. UiPath has a 52 week low of $9.38 and a 52 week high of $18.74.
Insiders Place Their Bets
In other UiPath news, CFO Ashim Gupta sold 240,874 shares of the firm’s stock in a transaction dated Thursday, October 9th. The shares were sold at an average price of $17.28, for a total transaction of $4,162,302.72. Following the transaction, the chief financial officer owned 696,117 shares of the company’s stock, valued at approximately $12,028,901.76. This trade represents a 25.71% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Daniel Dines sold 122,734 shares of the stock in a transaction on Wednesday, October 8th. The shares were sold at an average price of $14.89, for a total value of $1,827,509.26. Following the sale, the chief executive officer directly owned 613,670 shares in the company, valued at $9,137,546.30. This trade represents a 16.67% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 2,319,002 shares of company stock worth $34,094,875 in the last three months. Corporate insiders own 23.19% of the company’s stock.
Institutional Trading of UiPath
Analysts Set New Price Targets
A number of analysts have recently issued reports on the stock. Truist Financial decreased their price objective on shares of UiPath from $13.00 to $12.00 and set a “hold” rating on the stock in a research report on Friday, September 5th. DA Davidson started coverage on UiPath in a research note on Friday, September 5th. They issued a “neutral” rating and a $12.00 price target for the company. Canaccord Genuity Group decreased their price target on UiPath from $16.00 to $15.00 and set a “buy” rating on the stock in a report on Monday, September 8th. Zacks Research lowered UiPath from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 4th. Finally, UBS Group set a $17.00 target price on UiPath and gave the stock a “neutral” rating in a research report on Thursday, October 23rd. Two investment analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, UiPath presently has an average rating of “Hold” and a consensus target price of $13.71.
Read Our Latest Report on PATH
UiPath Company Profile
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
See Also
- Five stocks we like better than UiPath
- What is a Microcap Stock? Everything You Need to Know
- 3 Stocks You’ll Wish You Bought Before 2026
- Comparing and Trading High PE Ratio Stocks
- Wall Street Punished CrowdStrike for Beating Earnings? Seriously?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Okta: Excuses to Sell Vs. Reasons to Buy
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.
